Should You Buy CME Group Inc (CME) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
Not a good buy right now at ~$285. CME is in a strong uptrend, but the stock is short-term overextended (RSI_6 ~78) and is trading right under a key resistance zone (~285.34–289.25). For a beginner long-term investor who is impatient and wants to buy immediately, the risk/reward at this exact level is unfavorable versus waiting for even a modest pullback toward ~279 or below.
Technical Analysis
Trend is bullish: moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), indicating an established uptrend. However, momentum looks stretched: RSI_6 is ~78 (overbought/extended), which often precedes consolidation or a pullback. MACD histogram is positive (1.53) but 'positively contracting,' suggesting upside momentum is still positive but slowing. Price is sitting near resistance: Pivot ~279.01, R1 ~285.34 (current price ~285.05 is essentially at R1), next resistance R2 ~289.25. This setup favors a pause/pullback rather than an immediate clean breakout for a new long-term entry.
Analyst Ratings and Price Target Trends
Recent trend: price targets moved up at Morgan Stanley (to $320, Overweight) and Barclays (to $304, Equal Weight), while BofA remains bearish with an Underperform and a much lower target ($209). Wall Street pros: strong/healthy transactional activity and constructive market conditions into 2026 (supports CME’s fee/volume model). Wall Street cons: valuation and exchange outlook viewed more mixed by some, and at least one major firm sees limited upside/downside risk from current levels. Net: overall constructive but not unanimously bullish, and the stock’s current stretched technicals make 'buy right now' less compelling.
Wall Street analysts forecast CME stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CME is 285.9 USD with a low forecast of 209 USD and a high forecast of 320 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast CME stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CME is 285.9 USD with a low forecast of 209 USD and a high forecast of 320 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 284.480
Current: 284.480
